21st November 2019

Pure Drug Safety Sponsor Medilink East Midlands ‘Outstanding Achievement Award’

As a trusted partner providing Pharmaceutical Solutions, we understand the complexities and difficulties surrounding the journey from innovation to the marketplace. That’s why we are proud […]
22nd July 2019

Yellow fever vaccine

Yellow fever vaccine – following two fatalities – the vaccine must not be given to patients that present with a history of thymus dysfunction, or is […]
4th April 2019

Breast Implants Safety Concerns – the Importance of Post-Marketing Surveillance

Recently, (24 March 2019), the FDA have started to scrutinise the safety of breast implants, which brings into focus the importance of post-marketing surveillance in patient […]
4th April 2019

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC ) 11-15 March 2019

EU referral procedures for safety reasons: Just started – review on screening patients before treatment with fluorouracil, capecitabine, tegafur and flucytosine. The review to examine existing […]
21st March 2019

The World Tuberculosis Day – 24 March

TB is the world’s deadliest infectious killer. The disease is preventable and curable. Globally the TB mortality rate has reduced by 42% since 2000 (saving an […]